Werler Martha M, Starr Jacqueline R, Cloonan Yona K, Speltz Matthew L
Slone Epidemiology Center, Boston University, Boston, Massachusetts 02215, USA.
J Craniofac Surg. 2009 Mar;20 Suppl 1(Suppl 1):664-9. doi: 10.1097/SCS.0b013e318193d5d5.
Hemifacial microsomia (HFM) is a variable, complex malformation involving asymmetric hypoplasia of the face and ear. Little is known about the risk factors for or consequences of HFM. In this study, we describe 3 studies that have been or are currently being conducted to further our understanding of this malformation. The first completed study examined whether HFM risk is related to maternal exposures that may affect blood flow. In that case-control study, interview data from 230 mothers of children in the case group and 678 mothers of children in the control group suggested that maternal use of vasoactive medications in the first trimester, particularly in combination with cigarette smoking, was associated with increased risks of HFM. The second study is currently underway, in which we are evaluating whether HFM risk is related to genetic variation in pathways associated with vasculogenesis and hemostasis, using DNA collected in the first study. The third ongoing study observes children with HFM to identify psychosocial, cognitive, dental, and medical sequelae. When the children from the original case-control study are 6 or 7 years of age, mothers and teachers complete self-administered questionnaires that cover a wide range of psychosocial development domains. Preliminary analyses of 115 case and 314 control children suggest that children with HFM may have worse teacher-reported academic performance and possibly higher levels of internalizing behavior problems than control children. When data on the full study sample are available, further analyses will determine whether the preliminary findings remain and if they vary by HFM phenotype, parenting style, or indicators of social risk.
半侧颜面短小畸形(HFM)是一种多变的复杂畸形,涉及面部和耳部的不对称发育不全。关于HFM的风险因素或后果,人们知之甚少。在本研究中,我们描述了三项已经完成或正在进行的研究,以加深我们对这种畸形的理解。第一项完成的研究考察了HFM风险是否与可能影响血流的母体暴露有关。在该项病例对照研究中,来自病例组230名儿童的母亲和对照组678名儿童的母亲的访谈数据表明,母亲在孕早期使用血管活性药物,尤其是与吸烟同时使用时,与HFM风险增加有关。第二项研究正在进行中,我们正在利用第一项研究中收集的DNA评估HFM风险是否与血管生成和止血相关途径的基因变异有关。第三项正在进行的研究观察患有HFM的儿童,以确定心理社会、认知、牙齿和医学方面的后遗症。当最初病例对照研究中的儿童6或7岁时,母亲和教师完成涵盖广泛心理社会发展领域的自填问卷。对115名病例儿童和314名对照儿童的初步分析表明,与对照儿童相比,患有HFM的儿童教师报告的学业成绩可能更差,内化行为问题水平可能更高。当获得完整研究样本的数据时,进一步分析将确定初步研究结果是否仍然成立,以及它们是否因HFM表型、养育方式或社会风险指标而异。